More on HRMY
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $41.86 |
|
|||
| Open | $41.50 | ||||
| 52 Wk High | $1.35 | ||||
| 52 Wk Low | $0.10 | ||||
| Day High | $42.34 | ||||
| Day Low | $41.36 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 662,548 | ||||
- Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress
- Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference
- Wolfe Research Starts Harmony Biosciences Holdings Inc. (HRMY) at Outperform
- Form 144 Harmony Biosciences Hold Filed by: Valor IV Pharma Holdings, LLC
- Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium
- Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $70 at Oppenheimer
- Form 10-Q Harmony Biosciences Hold For: Jun 30
- Form 8-K Harmony Biosciences Hold For: Aug 04
- Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile
- Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $51 at Mizuho
Entities mentioned with HRMY
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
